Proyecto De Biomedicina Cima, S.l.

Pablo Sarobe Ugarriza

Juan José Lasarte Sagastibelza

Inés Noelia Casares Lagar

Jesús Maria Prieto Valtueña

Francisco Borras Cuesta

Francisco Borrás Cuesta

Javier Dotor De Las Herrerías

Lorea Manterola Careaga

Nancy Díaz-Valdés Farray

Jesús Prieto Valtueñ

Pedro Berraondo LÓPEZ

Jesús María Prieto VALTUEÑA

Cristina Mansilla Puerta

Marta Ruiz Egozcue

Aintzane Zabaleta Azpiroz

The invention relates to peptides of general formula (I), wherein X is absent or X is present and is Xor X-X, wherein Xand X, independently from one another, represent an amino acid; their functional variants and fragments, and their pharmaceutically acceptable salts, having the capacity to bind to scurfin and inhibit its biological activity, therefore they regulate or block the activity of regulatory T (Treg) lymphocytes. They are applicable in the treatment of infectious and neoplastic diseases. 

Peptides with capacity to bind to scurfin and applications

The invention relates to peptides having the capacity to bind to interleukin-10 (IL-10) and their use in the treatment of clinical conditions or pathological disorders associated to IL-10 expression, particularly to a high IL-10 expression, for example, infectious diseases, tumors, cancers and acute damage conditions.

Peptides with capacity for binding with interleukine 10 (IL-10)

Growing community of inventors

Pamplona, Spain

Pablo Sarobe Ugarriza